UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008610
Receipt number R000010119
Scientific Title To clarify different effects of daily and weekly hPTH(1-34), teriparatide, administration on local and systemic bone metabolism during healing period after vertebral fracture.
Date of disclosure of the study information 2012/08/06
Last modified on 2017/10/23 17:12:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

To clarify different effects of daily and weekly hPTH(1-34), teriparatide, administration on local and systemic bone metabolism during healing period after vertebral fracture.

Acronym

To test different effects of daily and weekly teriparatide on local and systemic bone metabolism during fracture healing after vertebral fracture

Scientific Title

To clarify different effects of daily and weekly hPTH(1-34), teriparatide, administration on local and systemic bone metabolism during healing period after vertebral fracture.

Scientific Title:Acronym

To test different effects of daily and weekly teriparatide on local and systemic bone metabolism during fracture healing after vertebral fracture

Region

Japan


Condition

Condition

osteoporosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify different effects of daily and weekly hPTH(1-34), teriparatide, administration during healing period after vertebral fracture on the fracture site, pain and systemic bone turnover, and different indication of those two agents.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

Bone metabolic markers

Key secondary outcomes

Vertebral and femoral bone mineral density, numbers of new vertebral fractures during the study period, VAS, JOQOL, RDQ, QUEST, and bony union


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation

YES

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Teriparatide Acetate

Interventions/Control_2

Teriparatide (Genetical Recombination)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Post-menopausal women of 60-y-o or above with sever osteoporosis who have a fresh vertebral fracture and understand, and literary approve to be included to this study.
#1; The fresh vertebral fracture, what occur during 2 weeks, is defined with history, physical examination and X-ray appearances and/or MRI of spine.
#2; The sever osteoporosis is diagnosed to a patient whose point is accounting for 3 or above by our appraisal standard as follow.
Point
70%YAM>BMD=/>65% 1
65%YAM>BMD=/>60% 2
60%YAM>BMD 3
New vertebral fracture 1
Using corticosteroid 1
Old vertebral fracture =1 1
Old vertebral fractures >1 2
Sever osteoporosis: total 3=/<

Key exclusion criteria

1. Patients in whom study drugs (teriparatide) are contraindicated
2. Serious renal, hepatic, or cardiac disease
3. Secondly osteoporosis
4. Patients who are considered inappropriate for enrollment by the investigator for any other reason

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinya Tanaka

Organization

Saitama Medical University

Division name

Department of Orthopaedic Surgery

Zip code


Address

Morohongo 38, moroyamacho, Irumagun, Saitamaken, Japan

TEL

049-276-1238

Email

tnk_sny@saitama-med.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinya Tanaka

Organization

Saitama Medical University

Division name

Department of Orthopaedic Surgery

Zip code


Address

350-0495, Morohongo 38, Moroyama-cho, Iruma-gun, Saitama, Japan

TEL

049-276-1238

Homepage URL


Email

tnk_sny@saitama-med.ac.jp


Sponsor or person

Institute

Saitama Medical University

Institute

Department

Personal name



Funding Source

Organization

Japan Osteoporosis Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

埼玉医科大学病院(埼玉県)、埼玉医科大学かわごえクリニック(埼玉県)、小川日本赤十字病院(埼玉県)、関越病院(埼玉県)、若葉病院(埼玉県)


Other administrative information

Date of disclosure of the study information

2012 Year 08 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 28 Day

Date of IRB


Anticipated trial start date

2012 Year 08 Month 06 Day

Last follow-up date

2014 Year 03 Month 31 Day

Date of closure to data entry

2014 Year 07 Month 31 Day

Date trial data considered complete

2014 Year 07 Month 31 Day

Date analysis concluded

2015 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2012 Year 08 Month 03 Day

Last modified on

2017 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010119


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name